Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.

scientific article published in November 1997

Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INTIMM/9.11.1627
P698PubMed publication ID9418124
P5875ResearchGate publication ID13812381

P50authorJeffrey L. BrowningQ42486462
P2093author name stringHochman PS
Rennert PD
P433issue11
P921main subjectlymph nodeQ170758
P304page(s)1627-1639
P577publication date1997-11-01
P1433published inInternational ImmunologyQ15710043
P1476titleSelective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.
P478volume9

Reverse relations

cites work (P2860)
Q34419871A revisit of mucosal IgA immunity and oral tolerance
Q34504235Aging impacts isolated lymphoid follicle development and function
Q40954925Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase
Q90229560Applying a weight of evidence approach to the evaluation of developmental toxicity of biopharmaceuticals
Q38839844Bioengineering of Artificial Lymphoid Organs
Q35145609Biological functions of tumor necrosis factor cytokines and their receptors
Q48709458Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis
Q47933757Cytokine regulation of secondary lymphoid organ development.
Q36209717Development of intestinal M cells.
Q34764895Development of secondary lymphoid organs
Q36369156Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice.
Q40865797Expression of lymphotoxins and their receptor-Fc fusion proteins by baculovirus
Q36404217Generation of splenic follicular structure and B cell movement in tumor necrosis factor-deficient mice.
Q39143550High Endothelial Venules and Other Blood Vessels: Critical Regulators of Lymphoid Organ Development and Function
Q35748193Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches
Q33464362Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals
Q74548133Initiation of NALT organogenesis is independent of the IL-7R, LTbetaR, and NIK signaling pathways but requires the Id2 gene and CD3(-)CD4(+)CD45(+) cells
Q34568588Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.
Q37069755Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.
Q47713223Lymph node genesis is induced by signaling through the lymphotoxin beta receptor
Q36426808Lymphoid organ development: from ontogeny to neogenesis
Q34488105Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen
Q35083503Lymphotoxin plays a crucial role in the development and function of nasal-associated lymphoid tissue through regulation of chemokines and peripheral node addressin
Q28568720Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury
Q36672549Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse transcription-PCR.
Q36544048New insights into the cell biology of the marginal zone of the spleen
Q38208275Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases
Q34079327Osteoprotegerin ligand: a regulator of immune responses and bone physiology.
Q28585776Overlapping roles of CXCL13, interleukin 7 receptor alpha, and CCR7 ligands in lymph node development
Q40561373Permanent correction of an inherited ectodermal dysplasia with recombinant EDA.
Q34725322Peyer's patches are required for oral tolerance to proteins
Q36478455Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs
Q36368551Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE
Q37206961Requirement for membrane lymphotoxin in natural killer cell development.
Q37576573Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid Tissues
Q36369671Splenic T zone development is B cell dependent
Q41841106Stroma cell priming in enteric lymphoid organ morphogenesis
Q28068106Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation
Q34690481TNFα-dependent development of lymphoid tissue in the absence of RORγt⁺ lymphoid tissue inducer cells
Q40755998The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis
Q36845128The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in mice
Q35216957The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity
Q24683018The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games
Q47713235The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues
Q37986126The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy.
Q44302153The role of apoptosis signal-regulating kinase 1 in lymphotoxin-beta receptor-mediated cell death.
Q35145632The role of lymphotoxin in development and maintenance of secondary lymphoid tissues
Q84587939[Experimental immunopathology and molecular pathology of infections]

Search more.